Download pdf
Research on the Impact of SARS-CoV-2 on Heart Health
- 1 Beijing No.101 High School, Beijing, 100055, China
* Author to whom correspondence should be addressed.
Abstract
Since the initial identification of SARS-CoV-2, its impact on heart health has been a subject of considerable interest. SARS-CoV-2 infection not only triggers respiratory symptoms but may also cause substantial damage to the heart and cardiovascular system, leading to conditions such as myocarditis, heart failure, and other cardiovascular events. Research indicates that these cardiac issues are particularly prominent in severe cases. This review examines the specific effects of SARS-CoV-2 infection on the heart, including changes in cardiac structure, Electrocardiogram (ECG) abnormalities, and variations in cardiac biomarkers such as troponin and B-type natriuretic peptide (BNP). It also explores the relationship between these changes and clinical outcomes in patients. In addition, by synthesizing current literature, the study reveals the multifaceted impact of SARS-CoV-2 on cardiac function and discusses its implications for clinical management. Notably, significant increases in biomarkers of myocardial injury, such as troponin and BNP, suggest possible cardiac damage or increased burden. The results highlight the importance of monitoring and protecting heart function in patients with SARS-CoV-2 infection. In short, the paper delves into the impact of SARS-CoV-2 on heart health and provides recommendations for further research and clinical practice to improve patient outcomes.
Keywords
SARS-CoV-2, Heart Health, Myocarditis, Abnormal Electrocardiogram.
[1]. WHO. (2023) COVID-19 Dashboard. World Health Organization.
[2]. Zheng, Y., et al. (2020) COVID-19 and the cardiovascular system. Nature Reviews Cardiology, 17(5): 259-260.
[3]. Patterson, K. J., et al. (2020). ACLF during COVID-19. Journal of Hepatology, 73(2): S19.
[4]. Bhatla, A., et al. (2020). COVID-19 and cardiac arrhythmias. Circulation: Arrhythmia and Electrophysiology, 13(6).
[5]. Wang, D., et al. (2020) Clinical characteristics of 138 hospitalized patients with nCoV pneumonia in Wuhan, China. JAMA, 323(11): 1061-1069.
[6]. Kotecha, D., et al. (2020) COVID-19 and Atrial Fibrillation: A Hospital Experience. European Heart Journal, 41(16): 1466-1468.
[7]. Geri, G., et al. (2021) Cardiac injury in COVID-19: An overview. European Journal of Preventive Cardiology, 28(3): 205-211.
[8]. Madjid, M., et al. (2020) Potential Effects of Coronaviruses on the Cardiovascular System. American Journal of Cardiology, 125(8): 1409-1414.
[9]. Wu, Z. and McGoogan, J.M. (2020) Characteristics of and Important Lessons from the Coronavirus Disease 2019 (COVID-19) Outbreak in China. JAMA, 323(13): 1239-1242.
[10]. Zhou, F., et al. (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet, 395(10229): 1054-1062.
[11]. Davis, H.E., et al. (2021) Long COVID: What we know and what we need to know. Nature Reviews Immunology, 21(11): 681-682.
[12]. Fowler, A. J., et al. (2022) Impact of COVID-19 vaccination on severe illness and mortality. Lancet Infectious Diseases, 22(3): e83-e93.
Cite this article
Wang,A. (2024).Research on the Impact of SARS-CoV-2 on Heart Health.Theoretical and Natural Science,63,128-132.
Data availability
The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.
Disclaimer/Publisher's Note
The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content
About volume
Volume title: Proceedings of the 4th International Conference on Biological Engineering and Medical Science
© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and
conditions of the Creative Commons Attribution (CC BY) license. Authors who
publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons
Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this
series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published
version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial
publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and
during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See
Open access policy for details).